Background Apolipoprotein C-III (apoC-III) is a regulator of triglyceride (TG) metabolism. and due to its association with risk of cardiovascular disease. is an emergent target for pharmacological intervention. The impact of substantially lowering apoC-III on lipoprotein metabolism is not clear. https://www.lolasalinas.com/